These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7874501)

  • 1. Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.
    Onoe H; Inoue O; Suzuki K; Tsukada H; Itoh T; Mataga N; Watanabe Y
    Brain Res; 1994 Nov; 663(2):191-8. PubMed ID: 7874501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
    Kobayashi K; Inoue O; Watanabe Y; Onoe H; Långström B
    J Neural Transm Gen Sect; 1995; 100(2):147-51. PubMed ID: 8962684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Brain Res; 1999 Sep; 841(1-2):160-9. PubMed ID: 10546998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET].
    Iyo M; Yamasaki T; Fukuda H; Inoue O; Suzuki K; Shinotoh H; Ito T; Yonezawa H; Nishio M; Koseki A
    Kaku Igaku; 1989 Feb; 26(2):213-20. PubMed ID: 2525202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of rhesus monkeys studied with positron emission tomography.
    Hartvig P; Eckernäs SA; Ekblom B; Lindström L; Lundqvist H; Axelsson S; Fasth KJ; Gullberg P; Långström B
    Acta Neurol Scand; 1988 Apr; 77(4):314-21. PubMed ID: 3260438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography.
    Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Leenders KL; Lundquist H; Antoni G; Gee A; Rimland A; Uhlin J
    Acta Neurol Scand; 1987 Oct; 76(4):283-7. PubMed ID: 2961191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of dopamine D
    Hashimoto K; Kakiuchi T; Ohba H; Nishiyama S; Tsukada H
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):173-176. PubMed ID: 27091456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Andersson J; Lilja A; Antoni G; Fasth KJ; Bjurling P; Westerberg G
    J Neural Transm Gen Sect; 1995; 102(3):189-208. PubMed ID: 8788068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release.
    Ishizu K; Smith DF; Bender D; Danielsen E; Hansen SB; Wong DF; Cumming P; Gjedde A
    Synapse; 2000 Oct; 38(1):87-101. PubMed ID: 10941144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
    Maggos CE; Tsukada H; Kakiuchi T; Nishiyama S; Myers JE; Kreuter J; Schlussman SD; Unterwald EM; Ho A; Kreek MJ
    Neuropsychopharmacology; 1998 Aug; 19(2):146-53. PubMed ID: 9629568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
    Hartvig P; Torstenson R; Tedroff J; Watanabe Y; Fasth KJ; Bjurling P; Långström B
    J Neural Transm (Vienna); 1997; 104(4-5):329-39. PubMed ID: 9295169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
    Aalto S; Ihalainen J; Hirvonen J; Kajander J; Scheinin H; Tanila H; Någren K; Vilkman H; Gustafsson LL; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 2005 Nov; 182(3):375-83. PubMed ID: 16001106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
    Nordström AL; Farde L; Eriksson L; Halldin C
    Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.